CSPC was selected as "2022 Top 100 Chinese Pharmaceutical Innovation Enterprises"


2022-09-22: [Chinese Article Link] Recently, the “E Pharmacy Manager” of the well-known pharmaceutical media, based on the data of the DerwentTM patent and the CortellisTM competitive intelligence and clinical trial, and based on the “3-D4” selection system, underwent a four-month data screening and integration analysis of the “100-strong


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.




Trending in China

What China Reads


CSPC was selected as "2022 Top 100 Chinese Pharmaceutical Innovation Enterprises"


2022-09-22: [Article Link] Recently, the “E Pharmacy Manager” of the well-known pharmaceutical media, based on the data of the DerwentTM patent and the CortellisTM competitive intelligence and clinical trial, and based on the “3-D4” selection system, underwent a four-month data screening and integration analysis of the “100-strong

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.